Collexis' Expert Profiling for the UK's Biomedical Research Community

Collexis Holdings, Inc.A new agreement was announced between Collexis Holdings Inc. (OTCBB: CLXS), a leading developer of semantic knowledge discovery software and expert profiles, and JISC Collections for an online resource, which aims to encourage greater collaboration and expand scientific knowledge amongst the biomedical research community in the UK. For specially negotiated subscription fees, researchers, teaching staff and students at universities and research councils in the UK, will be able to access Collexis' Expert Profiling. This online resource enables users to quickly identify experts within their institution as well as identify, locate and collaborate with other experts from around the world.

Using the Collexis system, subscribing institutions can create expert profiles of investigators, researchers and departments to disseminate ground-breaking research and biomedical advances. These profiles are generated using researchers’ publications from a variety of sources. Profiles are then available to all researchers, allowing them to easily find what is being published, what researchers are active and the pace of research in a particular area of interest.

"Collexis' Expert Profiling System fosters collaboration among researchers, allowing them to leverage the information of their colleagues and work to enhance, stimulate and create new ideas and discoveries," said Bill Kirkland, CEO of Collexis Holdings, Inc. "We are excited about working with JISC Collections to create internal expert profiling systems that bridge the gap between departments, cooperating organisations, basic research and clinical research."

Lorraine Estelle, CEO of JISC Collections, says that this agreement will "save users researchers time identifying expertise within their institutions, but provides opportunities for research and help widen access to essential sources of biomedical research. We also hope that it will encourage greater collaboration across our community through increased awareness and through the sharing of research outputs amongst institutions."

In addition to the new agreement with JISC Collections, Collexis Holdings Inc. is bringing its innovative technology to other research organisations and universities worldwide, including the Mayo Clinic Libraries; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Bristol-Myers Squibb; Lockheed Martin; World Health Organization, National Institutes of Health; and U.S. Department of Defense.

Collexis' Expert Profiling is available to all staff and students within a subscribing university or research council institution in the UK. Institutions wanting access to the service will be required to pay an annual subscription fee. For further information, please go to: http://www.jisccollections. ac.uk/catalogue/collexis_expert.

Related news articles:

About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of semantic search and knowledge discovery software is headquartered in Columbia, South Carolina (USA) with major operations in Cincinnati, Ohio, Geldermalsen, the Netherlands and Cologne, Germany. Collexis now offers the world’s first pre-populated scientific social network for life science researchers, www.biomedexperts.com. Collexis' proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined “fingerprinted” concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as "finding needles in many haystacks". Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis' current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit www.collexis.com.

About JISC Collections
JISC Collections was established as a mutual trading company by the UK further and higher education funding councils in 2006 to negotiate with publishers of online information and other owners of digital content. The range of resources licensed for use by such agreements constitutes a large national collection of online resources for education and research. JISC Collections is funded by JISC. For further information, please go to http://www.jisc-collections.ac.uk.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...